JPMorgan Chase & Co. Has $198.26 Million Holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

JPMorgan Chase & Co. raised its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 17.0% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,126,607 shares of the company's stock after buying an additional 454,044 shares during the quarter. JPMorgan Chase & Co. owned about 3.37% of Acadia Healthcare worth $198,258,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in the company. Wellington Management Group LLP grew its position in shares of Acadia Healthcare by 12.2% during the 3rd quarter. Wellington Management Group LLP now owns 11,658,253 shares of the company's stock valued at $739,250,000 after buying an additional 1,266,384 shares during the last quarter. William Blair Investment Management LLC boosted its stake in Acadia Healthcare by 20.7% in the second quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company's stock valued at $237,434,000 after acquiring an additional 604,070 shares during the period. State Street Corp grew its holdings in shares of Acadia Healthcare by 3.5% during the third quarter. State Street Corp now owns 2,819,911 shares of the company's stock valued at $178,811,000 after purchasing an additional 95,613 shares during the last quarter. Point72 Asset Management L.P. raised its position in shares of Acadia Healthcare by 0.5% during the 3rd quarter. Point72 Asset Management L.P. now owns 2,282,810 shares of the company's stock worth $144,753,000 after purchasing an additional 12,470 shares during the period. Finally, Geode Capital Management LLC boosted its position in Acadia Healthcare by 0.9% during the 3rd quarter. Geode Capital Management LLC now owns 1,613,198 shares of the company's stock valued at $102,320,000 after purchasing an additional 14,197 shares during the period.

Acadia Healthcare Price Performance

Shares of Acadia Healthcare stock traded up $1.07 during trading on Tuesday, hitting $39.65. The stock had a trading volume of 2,186,699 shares, compared to its average volume of 1,081,077. The business has a fifty day moving average of $41.63 and a two-hundred day moving average of $59.42. The firm has a market cap of $3.68 billion, a P/E ratio of 13.00, a PEG ratio of 1.77 and a beta of 1.30. Acadia Healthcare Company, Inc. has a fifty-two week low of $36.50 and a fifty-two week high of $87.77. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.01. The company had revenue of $815.60 million for the quarter, compared to analysts' expectations of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The business's revenue was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.91 EPS. On average, sell-side analysts expect that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the company. StockNews.com raised Acadia Healthcare from a "sell" rating to a "hold" rating in a research report on Thursday, December 19th. Royal Bank of Canada cut their price objective on shares of Acadia Healthcare from $94.00 to $64.00 and set an "outperform" rating on the stock in a research report on Monday, November 18th. KeyCorp initiated coverage on shares of Acadia Healthcare in a research report on Friday, October 11th. They issued a "sector weight" rating for the company. Deutsche Bank Aktiengesellschaft raised Acadia Healthcare from a "hold" rating to a "buy" rating and lifted their price target for the company from $45.00 to $75.00 in a report on Thursday, December 12th. Finally, Barclays cut their target price on Acadia Healthcare from $76.00 to $43.00 and set an "overweight" rating on the stock in a research note on Friday, November 22nd. Four investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $75.44.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.